Reversible ring opening and closure reactions of the triazine ligands derived from 1-phenylazo-2-naphthylamine and pyridine-2-aldehyde or quinoline-2-aldehyde - structure and reactivity of the palladium (II) complexes

New ligands containing a heterocyclic ring, L¹ (1-anilino-2-(2-pyridyl)-naphth[1,2-d]imidazol-1-io-3-ide), L² (2-phenyl-3-(2-pyridyl)-3,4-dihydro-naphtho[2,1-e][1,2,4]triazin-1-io-4-ide), and L³ (1-anilino-2-(2-quinolyl)-naphth[1,2-d]imidazol-1-io-3-ide), and their palladium (II) complexes have been prepared. Structures of the ligands and the complexes were determined by X-ray crystallography. The mononuclear square-planar complexes of [PdCl₂(Lⁿ)] (n = 1 (1), n = 2 (2) and n = 3 (3)) had didentate Lⁿ (n = 1-3) ligands. The Lⁿ (n = 1-3) ligands were stable and their absorption spectra did not change in dichloromethane and methanol. On the other hand, the absorption spectrum of [PdCl₂(L²)] (2) in dichloromethane changed rapidly when methanol was added to the solution, and [PdCl(L^4b)] (5) (L^4b = N-[methoxy(2-pyridyl)methyl]-1-(phenylazo)-2-naphthylamide) was obtained from the concentrated reaction mixture. In this reaction, the dihydrotriazine ring of the didentate L² ligand in complex 2 opened and the resulting tridentate L^4b ligand coordinated to the Pd atom in complex 5. When an excess amount of (ⁿBu)₄NCl was added to complex 5 in dichloromethane, the absorption spectrum reverted to that of complex 2. Thus, the reversible ring opening and closure reactions of the coordinating dihydrotriazine ligand were observed. We also prepared [PdCl₂(L⁵)] (9) (L⁵ = 1-(phenylazo)-N-[1-(2-pyridyl)ethylidene]-2-naphthylamine) and determined the structure. It is noted that neither the ring closure reaction nor the coordination of the azo nitrogen atom of the L⁵ ligand occurred in complex 9.     

Solution and solid-state complexes of the potentially tetradentate pyridyl-thiazole ligand 6,6′-bis(4-methylthiazol-2-yl)-2,2′-bipyridine with Co, Ni, Cu, Cd, Hg, Cu and Ag

Reaction of the potentially tetradentate N-donor ligand 6,6′-bis(4-methylthiazol-2-yl)-2,2′-bipyridine (L¹) with the transition metal dications Co^II, Ni^II, Cu^II, Cd^II and Hg^II results in the formation of mononuclear [M(L¹)]²⁺ complexes, in which a planar ligand coordinates to the metals via all four N-donors. In contrast, reaction of L¹ with Cu^I and Ag^I monocations, affords dinuclear double stranded helicate species [M₂(L¹)₂]²⁺ (where M = Cu^I or Ag^I), in which partitioning of the ligand into two bis-bidentate pyridyl-thiazole chelating units allows each ligand to bridge both metal centres. X-Ray crystallography, electrospray mass spectroscopy and NMR spectroscopy reveal that the complexes [M_n(L¹)_m]^z+ (where n = 1, m = 1 and z = 2, when M = Co^II, Ni^II, Cu^II, Cd^II and Hg^II; n = 2, m = 2 and z = 2, when M = Cu^I), retain their solid-state structures in solution. Conversely, whilst ¹H NMR studies suggest that combination of equimolar amounts of Ag(X)(where ) and L¹ (in either nitromethane or acetonitrile) results in the formation of a helicate in solution, in the solid-state, an anion-templating effect gives rise to either mononuclear or dinuclear helicate structures [Ag_n(L¹)_n][X]_n (where n = 2 when X = OTf⁻; n = 1 when ).     

Synthesis and characterisation of new N1-alkyl-3,5-dipyridylpyrazole derived ligands. Study of their reactivity with Pd(II) and Pt(II)

Two new pyrazole-derived ligands, 1-ethyl-3,5-bis(2-pyridyl)pyrazole (L¹) and 1-octyl-3,5-bis(2-pyridyl)pyrazole (L²), both containing alkyl groups at position 1 were prepared by reaction between 3,5-bis(2-pyridyl) pyrazole and the appropriate bromoalkane in toluene using sodium ethoxide as base.The reaction between L¹, L² and [MCl₂(CH₃CN)₂] (M = Pd(II), Pt(II)) resulted in the formation complexes of formula [MCl₂(L)] (M = Pd(II), L = L¹ (1); M = Pd(II), L = L² (2); M = Pt(II), L = L¹ (3); M = Pt(II), L = L² (4)). These complexes were characterised by elemental analyses, conductivity measurements, infrared, ¹H, ¹³C{¹H} NMR and HMQC spectroscopies. The X-ray structure of the complex [PtCl₂(L²)] (4) was determined. In this complex, Npyridine and Npyrazole donor atoms coordinate the ligand to the metal, which complete its coordination with two chloro ligands in a cis disposition.     

One-pot syntheses of alkenyl-phosphonio complexes of ruthenium(II), rhodium(III) and iridium(III) bearing p-cymene or pentamethylcyclopentadienyl groups

Reaction of [(p-cymene)RuCl₂(PPh₃)] (1) or [Cp^∗MCl₂(PPh₃)] (Cp^∗ = C₅Me₅) (3a: M = Rh; 4a: M = Ir) with 1-alkynes and PPh₃ were carried out in the presence of KPF₆, generating the corresponding alkenyl-phosphonio complexes, [(p-cymene)RuCl(PPh₃){CHCR(PPh₃)}](PF₆) (2a: R = Ph; 2b: R = p-tolyl) or [Cp^∗MCl(PPh₃){CHCPh(PPh₃)}](PF₆) (5: M = Rh; 6: M = Ir). Similar reactions of complexes [Cp^∗RhCl₂(L¹)] (3a: L¹ = PPh₃; 3c: L¹ = P(OMe)₃) with L² (L² = PPh₃, PMePh₂, P(OMe)₃) gave [Cp^∗RhCl(L¹)(L²)](PF₆) (7bb: L¹ = L² = PMePh₂; 7ca: L¹ = P(OMe)₃, L² = PPh₃; 7cc: L¹ = L² = P(OMe)₃). Alkenyl-phosphonio complex 5 was treated with P(OMe)₃ or 2,6-xylyl isocyanide, affording [Cp^∗RhCl(L){CHCPh(PPh₃)}](PF₆) (8a: L = P(OMe)₃; 8b: L = 2,6-xylNC). X-ray structural analyses of 2a, 6 and 8a revealed that the phosphonium moiety bonded to the C_β atom of the alkenyl group are E configuration.     

Pd(II) complexes containing N-alkyl-3-pyridine-5-trifluoromethyl pyrazole ligands: Synthesis, NMR studies and X-ray crystal structures

Palladium [PdCl₂(L)] complexes with N-alkylpyridylpyrazole derived ligands [2-(5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L¹), 2-(1-ethyl-5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L²), 2-(1-octyl-5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L³), and 2-(3-pyridin-2-yl-5-trifluoromethyl-pyrazol-1-yl)ethanol (L⁴) were synthesised. The crystal and molecular structures of [PdCl₂(L)] (L = L², L³, L⁴) were resolved by X-ray diffraction, and consist of monomeric cis-[PdCl₂(L)] molecules. The palladium centre has a typical square-planar geometry, with a slight tetrahedral distortion. The tetra-coordinate metal atom is bonded to one pyridinic nitrogen, one pyrazolic nitrogen and two chlorine ligands in cis disposition. Reaction of L (L², L⁴) with [Pd(CH₃CN)₄](BF₄)₂, in the ratio 1M:2L, gave complexes [Pd(L)]₂(BF₄)₂. Treatment of [PdCl₂(L)] (L = L², L⁴) with NaBF₄ and pyridine (py) and treatment of the same complexes with AgBF₄ and triphenylphosphine (PPh₃) yielded [Pd(L)(py)₂](BF₄)₂ and [Pd(L)(PPh₃)₂](BF₄)₂ complexes, respectively. Finally, reaction of [PdCl₂(L⁴)] with 1 equiv of AgBF₄ yields [PdCl(L⁴)](BF₄).     

Palladium(II), platinum(II), ruthenium(II) and mercury(II) complexes of potentially tridentate Schiff base ligands of (E, N, O) type (E = S, Se, Te): Synthesis, crystal structures and applications in Heck and Suzuki coupling reactions

Schiff bases of 2-hydroxybenzophenone (HBP) (C₆H₅)(2-HOC₆H₄)CN(CH₂)_nEAr (L1/L2: E = S, Ar = Ph, n = 2/3; L3/L4: E = Se, Ar = Ph, n = 2/3; L5/L6: E = Te, Ar = 4-MeOC₆H₄, n = 2/3) and their complexes [PdCl(L-H)] (L = L1−L6; 1, 2, 3, 5, 7, 11), [PtCl(L3-H/L5-H)] (4/8), [PtCl₂(L4/L6)₂] (6/12), [(p-cymene)RuCl(L5/L6)]Cl (9/13) and [HgBr₂(L5/L6)₂] (10/14) have been synthesized and characterized by proton, carbon-13, selenium-77 and tellurium-125 NMR, IR and mass spectra. Single crystal structures of L1, 1, 3, 4, 5 and 7 were solved. The Pd-E bond distances (Å): 2.2563(6) (E = S), 2.3575(6)−2.392(2) (E = Se); 2.5117(5)−2.5198(5) (E = Te) are near the lower end of the bond length range known for them. The Pt-Se bond length, 2.3470(8) Å, is also closer to the short values reported so far. The Heck and Suzuki reaction were carried out using complexes 1, 3, 5 and 7 as catalysts under aerobic condition. The percentage yields for trans product in Heck reaction were found upto 85%.     

Two new end-to-end single dicyanamide bridged Cu(II) complexes with Schiff base ligands: Structural, electrochemical and magnetic properties

The synthesis, crystal structures and magnetic properties of two different copper(II) complexes of formula [Cu(L¹)(dca)]_n · nClO₄ (1) and [Cu(L²)]₂(dca)(ClO₄) (2) [L¹ = N,N-dimethylethylene-N′-(pyridine-2-carbaldiiminato), HL² = N,N-dimethylethylene-N′-salicylaldiiminato, dca = dicyanamide anion] are described. Spectroscopic and electrochemical properties have also been discussed. A one-dimensional chain structure with single, symmetrical, μ_1,5-dca bridges is found in compound 1. The copper atom in 1 has a square pyramidal geometry. A tridentate Schiff base ligand, having NNN donor sites, and one nitrogen atom from dca occupy the basal plane. N(18) of a neighbouring unit occupies the apical site. The Schiff base used in compound 2 is a tridentate anion with NNO donor sites, which changes the structure in a dinuclear unit of copper atoms bridged by single end-to-end dicyanamide ion. The environment around copper in 2 is square planar. Magnetic susceptibility measurements for 1 and 2 reveal the occurrence of weak antiferromagnetic interaction through the dca ligand.     

Molecular interactions of zinc(II) cyclams with polycarboxylato ligands

Four new zinc(II) cyclams of the composition {Zn(L)(tp²⁻) · H₂O}_n (1), {Zn(L)(H₂bta²⁻) · 2H₂O}_n (2), [Zn₂(L)₂(ox²⁻)] 2ClO₄ · 2DMF (3), and Zn(L)(H₂btc⁻)₂ · 2DMF (4), where L = cyclam, tp²⁻ = 1,4-benzenedicarboxylate ion, H₂bta²⁻ = 1,2,4,5-benzenetetracarboxylate ion, ox²⁻ = oxalate ion, DMF = N,N-dimethylformamide, and H₂btc⁻ = 1,3,5-benzenetricarboxylate ion, have been synthesized and structurally characterized by a combination of analytical, spectroscopic and crystallographic methods. The carboxylato ligands in the complexes 1-4 show strong coordination tendencies toward zinc(II) cyclams with hydrogen bonding interactions between the pre-organized N-H groups of the macrocycle and oxygen atoms of the carboxylato ligands. The macrocycles in 1, 2, and 4 adopt trans-III configurations with the appropriate R,R,S,S arrangement of the four chiral nitrogen centers, respectively. However, the complex 3 shows an unusual cis V conformation with the R,R,R,R nitrogen configuration. The finding of strong interactions between the carboxylato ligands and the zinc(II) ions may provide additional knowledge for the improved design of receptor-targeted zinc(II) cyclams in anti-HIV agents.     

Mononuclear iron(III) complexes supported by tripodal N3O ligands: Synthesis, structure and reactivity towards DNA cleavage

A new synthetic route to the known tripodal tetradentate N₃O ligand L¹ (HL¹ = [N-(3,5-di-tert-butyl-2-hydroxybenzyl)-N,N-di-(2-pyridylmethyl)]amine) is reported. The related compounds HLⁿ (n = 2, 3) were prepared by a similar procedure. Treatment of HLⁿ (n = 1-3) with FeCl₃·6H₂O in hot methanol led to the mononuclear iron(III) complexes [Fe(Lⁿ)Cl₂] (1: n = 1, 2: n = 2, 3: n = 3). The solid-state structures of complexes 1 and 2 were determined by X-ray crystallography. [Fe(L¹)Cl₂] (1) showed effective nuclease activity in the presence of hydrogen peroxide, converting supercoiled plasmid DNA to its linear form.     

Structure and properties of a macrocyclic silver(II) supramolecular polymer

A new silver(II) complex, {[Ag(L1)](NO₃)₂·4H₂O}_n (1) (L = 3,14-dimethyl-2,6,13,17-tetraazatricyclo[14,4,0^1.18,0^7.12] docosane) has been synthesized and structurally characterized by a combination of analytical, spectroscopic, electrochemical and X-ray diffraction methods. The complex 1 exhibits a 1D supramolecular polymer with the silver(II) macrocycle L1 and nitrate ions, where 1D chain is formed by hydrogen bonds between the two sets of pre-organized N-H groups of the macrocycle and nitrate ions. The lattice water molecules mediate to interconnect each 1D chain to form the 2D supramolecular sheet. In 1 the unusual high oxidation state of Ag(II) is stabilized by the tetraazamacrocyclic ligand L1. The cyclic voltammogram for 1 indicates that the electrochemical oxidation of [Ag(L1)]²⁺ is an irreversible process.     

Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands

The first [Pd(Lⁿ)₂(ox)] xH₂O oxalato(ox) complexes involving 2-chloro-N6-(benzyl)-9-isopropyladenine (L¹; complex 1), 2-chloro-N6-(4-methoxybenzyl)-9-isopropyladenine (L²; 2), 2-chloro-N6-(2,3-dimethoxybenzyl)-9-isopropyladenine (L³; 3), 2-chloro-N6-(2,4-dimethoxybenzyl)-9-isopropyladenine (L⁴; 4), and 2-chloro-N6-(4-methylbenzyl)-9-isopropyladenine (L⁵; 5) have been synthesized by the reactions of potassium bis(oxalato)palladate(II) dihydrate, [K₂Pd(ox)₂]·2H₂O, with the mentioned organic compounds (H₂ox = oxalic acid; x = 0 for 1-3 and 5 or 2 for 4). Elemental analyses (C, H, N), FTIR, Raman and NMR (¹H, ¹³C, ¹⁵N) spectroscopies, conductivity measurements and thermal studies (thermogravimetric and differential thermal analyses, TG/DTA) have been used to characterize the prepared complexes. The molecular structures of [Pd(L²)₂(ox)] (2) and [Pd(L⁵)₂(ox)]·L⁵·Me₂CO (5·L⁵·Me₂CO) have been determined by a single crystal X-ray analysis. The geometry of these complexes is slightly distorted square-planar with two appropriate Lⁿ (n = 2 or 5) molecules mutually arranged in the head-to-head (2) or head-to-tail (5) orientation. The Lⁿ ligands are coordinated to the central Pd(II) ion via the N7 atoms. The same conclusions regarding the binding properties of L¹-L⁵ ligands can be made based on multinuclear NMR spectra. In vitro cytotoxicity of the complexes 1-5 has been evaluated against human chronic myelogenous leukaemia (K562) and human breast adenocarcinoma (MCF7) cancer cell lines. Significant cytotoxicity has been determined for the complexes 3 (IC₅₀ = 6.2 μM) and 5 (IC₅₀ = 6.8 μM) on the MCF7 cell line, which is even better than that found for the well-known and widely-used platinum-bearing antineoplastic drugs, i.e. oxaliplatin and cisplatin.     

Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH)

Two new organotin(IV) complexes with dianionic dipeptides containing the α-aminoisobutyryl residue (Aib) as ligands are described. The solid complexes [(n-Bu)₂Sn(H₋₁L_A)] · 2MeOH (1 · 2MeOH) (L_AH = H-Aib-L-Leu-OH) and [(n-Bu)₂Sn(H₋₁L_B)] · MeOH (2 · MeOH) (L_BH = H-Aib-L-Ala-OH) have been isolated and characterized by single-crystal X-ray crystallography and spectroscopic techniques (H₋₁L²⁻ is the dianionic form of the corresponding dipeptide). Complexes 1 · 2MeOH and 2 · MeOH are monomeric with similar molecular structures. The doubly deprotonated dipeptide behaves as a N(amino), N(peptide), O(carboxylate) ligand and binds to the Sn^IV atom. The five-coordinate metal ion has a distorted trigonal bipyramidal geometry. A different network of intermolecular hydrogen bonds in each compound results in very dissimilar supramolecular features. The IR, far-IR, Raman and ¹¹⁹Sn NMR data are discussed in terms of the nature of bonding and known structures. The antibacterial and antiproliferative activities as well as the effect of the new compounds on pDNA were examined. Complexes 1 and 2 are active against the gram-positive bacteria Bacillus subtilis and Bacillus cereus. The IC₅₀ values reveal that the two compounds express promising cytotoxic activity in vitro against a series of cell lines.     

Synthesis and crystal structure of a salicylatooxovanadium(V) complex of an aminebis(phenolate) ligand: Kinetic studies on its formation from corresponding alkoxo complexes

Synthesis and single crystal X-ray structures of H₂L¹ and VO(L¹)(HL) [H₂L¹ = N,N-bis(2-hydroxy-3,5-ditertiarybutyl)-N′,N′-dimethylethylendiamine) or simply aminebis(phenol) and H₂L = salicylic acid) are reported here. The complex [VO(L¹)(HL)] is in distorted octahedral geometry under O₄N₂ donor environment where the basal core is defined by O(1), O(3), O(2) and N(5) atoms and two axial coordinates are occupied by O(4), an alkoxo-group and N(1), an imino-nitrogen atom. The electron spray mass spectrometric study on [VO(L¹)(HL)] in MeCN clearly points out the existence of single species in solution. Again, the ⁵¹V NMR of the bulk polycrystalline sample reveals that the complex [VO(L¹)(HL)] mainly exists in three out of four possible isomers. The formation of [VO(L¹)(HL)] from both [VO(L¹)(OMe)] and [VO(L¹)(OEt)] was followed kinetically by reacting with salicylic acid in MeCN. The presence of isosbestic point indicates a clean conversion of the reactants to product.     

Synthesis, characterization and biological studies of organotin(IV) complexes with hydrazone ligand

Four organotin(IV) complexes with general formula [RSnCl_n−1(TCB)] [R = Ph₂, n = 2 (2); R = Me, n = 3 (3); R = Bu, n = 3 (4); R = Ph, n = 3 (5)] have been synthesized by direct reaction of thiophene-2-carboxaldehyde benzhydrazone ligand [HTCB, (1)], base and organotin(IV) chloride in absolute methanol under N₂ atmosphere. All organotin(IV) complexes were characterized by elemental analyses, molar conductivity, UV-Vis, FT-IR, ¹H and ¹³C NMR spectral studies. Among them, diphenyltin(IV) complex (2) has also been characterized by X-ray crystallography diffraction analyses. The cytotoxicity of the hydrazone ligand as well as its organotin(IV) complexes (2-5) were determined with Artemia salina. While no-choice bioassay was employed on Coptotermes sp. to evaluate the termiticidal effect of all the complexes. Besides, the ligand (1) and its organotin(IV) complexes (2-4) were also tested against five types of bacteria namely Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Salmonella typhi.     

From infinite tubular arrays to discrete molecules and back: An example of reversible ring-opening polymerization in silver(I)-diphosphazane chemistry

The reaction of AgX with the diphosphazane ligand, PrⁱN(PPh₂)₂ (L) gives the polymeric complexes, [Ag₂(μ-X)₂(μ-L)]_n (X = NO₃1a or OSO₂CF₃1b). Single crystal X-ray analysis of 1a reveals a novel structural motif formed by interlinking of giant 40-membered rings; the diphosphazane ligand L adopts a unique ‘C_s’ geometry. These polymeric complexes exhibit a completely reversible ring-opening polymerization-depolymerization relationship with the dinuclear and mononuclear complexes, [{Ag(μ-L)(X)}₂] (X = NO₃2a, X = OSO₂CF₃2b) and [Ag(κ²-L)₂]X (X = NO₃3a, X = OSO₂CF₃3b).     

Synthesis and structure of dichloropalladium(II) complexes of heteroleptic N,S- and N,Se-donor ligands based on the 2-organochalcogenomethylpyridine motif, and Mizoroki-Heck catalysis mediated by complexes of N,S-donor ligands

Ligands containing the 2-organochalcogenomethylpyridine motif with substituents in the 4- or 6-position of the pyridyl ring, R⁴,R⁶-pyCH₂ER¹ [R⁴ = R⁶ = H, ER¹ = SMe (1), SeMe (2), SPh (6), SePh (7); R⁴ = Me, R⁶ = H, ER¹ = SMe (3), SPh (8), SePh (9); R⁴ = H, R⁶ = Me, ER¹ = SMe (4), SPh (10), SePh (11); R⁴ = H, R⁶ = Ph, ER¹ = SMe (5), SPh (12), SePh (13)] are obtained on the reaction of R⁴,R⁶-pyMe with LiBuⁿ followed by R¹EER¹. On reaction with PdCl₂(NCMe)₂, the ligands with a 6-phenyl substituent form cyclopalladated species PdCl{6-(o-C₆H₄)pyCH₂ER¹-C,N,E} (5a, 12a, 13a) with the structure of 13a (ER¹ = SePh) confirmed by X-ray crystallography; other ligands form complexes of stoichiometry PdCl₂(R⁴,R⁶-pyCH₂ER¹). Complexes with R⁶ = H are monomeric with N,E-bidentate configurations, confirmed by structural analysis for 3a (R⁴ = Me, ER¹ = SMe), 7a (R⁴ = H, ER¹ = SePh) and 9a (R⁴ = Me, ER¹ = SePh). Two of the 6-methyl substituted complexes examined by X-ray crystallography are oligomeric with trans-PdCl₂(N,E) motifs and bridging ligands, trimeric [PdCl₂(μ-6-MepyCH₂SPh-N,S)]₃ (10a) and dimeric [PdCl₂(μ-6-MepyCH₂SePh-N,Se)]₂ (11a). This behaviour is attributed to avoidance of the Me···Cl interaction that would occur in the cis-bidentate configuration if the pyridyl plane had the same orientation with respect to the coordination plane as observed for 3a, 7a and 9a [dihedral angles 8.0(2)-16.8(2)°]. When examined as precatalysts for the Mizoroki-Heck reaction of n-butyl acrylate with aryl halides in N,N-dimethylacetamide at 120 °C, the complexes exhibit the anticipated trends in yield (ArI > ArBr > ArCl, higher yield for electron withdrawing substituents in 4-RC₆H₄Br and 4-RC₆H₄Cl). The most active precatalysts are PdCl₂(R⁴-pyCH₂SMe-N,S) (R = H (1a), Me (3a)); complexes of the selenium containing ligands exhibit very low activity. For closely related ligands, the changes SMe to SPh, 6-H to 6-Me, and 6-H to 6-Ph lead to lower activity, consistent with involvement of both the pyridyl and chalcogen donors in reactions involving aryl bromides. The precatalyst PdCl₂(pyCH₂SMe-N,S) (1a) exhibits higher activity for the reaction of aryl chlorides in Buⁿ₄NCl at 120 °C as a solvent under non-aqueous ionic liquid (NAIL) conditions.     

Transition metal complexes based on pyridine ligand containing both bis(2-pyridyl) and 1,3-dithiole-2-ylidene units: Syntheses, structures, and magnetic studies

Two new mononuclear spin-crossover iron(II) complexes, [FeL₂(NCS)₂] · H₂O (1) and [FeL₂(NCSe)₂] (2), have been synthesized from the reaction of the versatile ligand 4,5-bis(2-cyanoethylthio)-2-bis(2-pyridyl)methylene-1,3-dithiole (L), Fe(ClO₄)₂, and KNCX (X = S/Se). Reactions of L with Cu^II or Co^II salts afford one mononuclear complex [CuL(hfac)₂] · CH₃OH (hfac = hexafluoroacetylacetonate) (3), one dinuclear complex [(CuLCl)₂(μ-Cl)₂] · CH₃OH (4), and two 1D chain species, [CuL₂]_n(BF₄)_2n (5) and [CoL₂]_n(ClO₄)_2n · 2nCH₂Cl₂ (6). The crystal structures of complexes 1 and 3-6 have been determined by X-ray crystallography. Short intermolecular S?S contacts between neighboring 1D arrays are observed in 5 and 6, which lead to the formation of the 2D structure. The magnetic properties are studied, and antiferromagnetic couplings between the Cu^II centers across the chloride bridges have been found in 4 (J = 2.04 cm^-1). Spin-crossover behaviors between high and low spin states are observed at T_1/2 = 80 K for 1 and T_1/2 = 300 K for 2, respectively.     

Reaction of [MCl2(CH3CN)2] (M = Pd(II), Pt(II)) compounds with N1-alkylpyridylpyrazole-derived ligands

Palladium(II) and platinum(II) complexes with N-alkylpyridylpyrazole-derived ligands, 2-(1-ethyl-5-phenyl-1H-pyrazol-3-yl)pyridine (L¹) and 2-(1-octyl-5-phenyl-1H-pyrazol-3-yl)pyridine (L²), cis-[MCl₂(L)] (M = Pd(II), Pt(II)), have been synthesised. Treatment of [PdCl₂(L)] (L = L¹, L²) with excess of ligand (L¹, L²), pyridine (py) or triphenylphosphine (PPh₃) in the presence of AgBF₄ and NaBPh₄ produced the following complexes: [Pd(L)₂](BPh₄)₂, [Pd(L)(py)₂](BPh₄)₂ and [Pd(L)(PPh₃)₂](BPh₄)₂. All complexes have been characterised by elemental analyses, conductivity, IR and NMR spectroscopies. The crystal structures of cis-[PdCl₂(L²)] (2) and cis-[PtCl₂(L¹)] (3) were determined by a single crystal X-ray diffraction method. In both complexes, the metal atom is coordinated by one pyrazole nitrogen, one pyridine nitrogen and two chlorine atoms in a distorted square-planar geometry. In complex 3, π-π stacking between pairs of molecules is observed.     

The first iron(III) complexes with cyclin-dependent kinase inhibitors: Magnetic, spectroscopic (IR, ES+ MS, NMR, Fe Mössbauer), theoretical, and biological activity studies

The first Fe^III complexes 1-6 with cyclin-dependent kinase (CDK) inhibitors of the type [Fe(L_n)Cl₃]·nH₂O (n = 0 for 1, 1 for 2, 2 for 3-6; L₁-L₆ = C2- and phenyl-substituted CDK inhibitors derived from 6-benzylamino-9-isopropylpurine), have been synthesized and characterized by elemental analysis, IR, ⁵⁷Fe Mössbauer, ¹H and ¹³C NMR, and ES+ mass spectroscopies, conductivity and magnetic susceptibility measurements, and thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC). The study revealed that the compounds are mononuclear, tetrahedral high-spin (S = 5/2) Fe^III complexes with an admixture of an S = 3/2 spin state originating probably from five-coordinated Fe^III ions either connecting with a bidentate coordination mode of the CDK inhibitor ligand or relating to the possibility that one crystal water molecule enters the coordination sphere of the central atom in a portion of molecules of the appropriate complex. Nearly spin-only value of the effective magnetic moment (5.82 μ_eff/μ_B) was determined for compound 1 due to absence of crystal water molecule(s) in the structure of the complex. Based on NMR data and DFT calculations, we assume that the appropriate organic ligand is coordinated to the Fe^III ion through the N7 atom of a purine moiety. The cytotoxicity of the complexes was tested in vitro against selected human cancer cell lines (G-361, HOS, K-562 and MCF-7) along with the ability to inhibit the CDK2/cyclinE kinase. The best cytotoxicity (IC₅₀: 4-23 μM) and inhibition activity (IC₅₀: 0.02-0.09 μM) results have been achieved in the case of complexes 2-4, and complexes 3, 4 and 6, respectively. In addition, the X-ray structure of 2-chloro-6-benzylamino-9-isopropylpurine, i.e. a precursor for the preparation of L₁, L₄ and L₅, is also described.     

Syntheses and characterization of triorganotin(IV) complexes of Schiff base derive from 4-amino-5-phenyl-4H-1,2,4-triazole-3-thiol and 5-amino-1,3,4-thiadiazole-2-thiol with p-phthalaldehyde

Eight triorganotin complexes of the types [(R₃Sn)₂(C₂₄H₁₆N₈S₂)].Y (R = Ph, Y = 0 (1); R = PhCH_2, Y = 2CH₃OH (2); R = n-Bu, Y = 0 (3)), [(R₃Sn)₂(C₂₄H₁₆N₈S₂)]_n (R = Me (4)), [(R₃Sn)₂(C₁₂H₆N₆S₄)] · Y (R = Ph, Y = CH₂Cl₂ (5); R = PhCH_2, Y = 0 (6)) and [(R₃Sn)₂(C₁₂H₆N₆S₄)] (R = Bu (7), R = Me (8)) have been obtained by H₂L₁ (H₂L₁ derived from 4-amino-5-phenyl-4H-1,2,4-triazole-3-thiol) and H₂L₂ (H₂L₂ derived from 5-amino-1,3,4-thiadiazole-2-thiol) with triorganotin chloride in the presence of sodium ethoxide. All the complexes were characterized by elemental, IR and NMR spectra analyses, except for complexes 1, 3, 6 and 8, other complexes were also characterized by X-ray diffraction analyses, which reveal that complexes 2 and 5 are dinuclear structures, complex 4 has a 2D network structure and complex 7 forms a macrocyclic structure linked by intermolecular N → Sn interactions.